Yep not much there IMO. Seems clear internally the capital management ideas are different to many shareholder's and maybe potential investors? No BB, no Company purchase, no interim div, no material change in staff (although it's growing slowly IMO) -any or all might help the investment sentiment. There's always external risks so this conservative approach is a knock against them for potential investment. I hope PW does focus on a couple of what should be near term revenue boosters outside Vitiligo - the photocosmetics launch and ACTH (which seems something went amiss?). Other staff seem to be in control of EPP and Vitiligo for now. Can't dream for miracles so another 6 months of pretty ho hum unless full year surprises?
CUV Price at posting:
$9.82 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)